嘉事堂(002462) - 2024 Q1 - 季度财报

Revenue and Profit - The company's revenue for Q1 2024 reached ¥7,442,979,521.58, representing a 10.17% increase compared to ¥6,756,081,779.54 in the same period last year[5] - Net profit attributable to shareholders was ¥75,533,309.91, up 11.51% from ¥67,734,160.88 year-on-year[5] - Total operating revenue for Q1 2024 reached ¥7,442,979,521.58, an increase of 10.14% compared to ¥6,756,081,779.54 in the same period last year[19] - Net profit for Q1 2024 was ¥117,353,880.03, representing a 20.19% increase from ¥97,598,224.23 in Q1 2023[19] - The total comprehensive income for Q1 2024 reached ¥117,353,880.03, representing a 20.2% increase from ¥97,598,224.23 in Q1 2023[20] - The net profit attributable to the parent company for Q1 2024 was ¥75,533,309.91, an increase of 11.8% compared to ¥67,734,160.88 in Q1 2023[20] - The net profit for minority shareholders was ¥41,820,570.12, up 40.0% from ¥29,864,063.35 in the previous year[20] Earnings Per Share - Basic and diluted earnings per share increased by 11.50% to ¥0.2589 from ¥0.2322[5] - Basic and diluted earnings per share for Q1 2024 were both ¥0.2589, compared to ¥0.2322 in Q1 2023, reflecting an increase of 11.6%[20] Cash Flow - The net cash flow from operating activities decreased significantly by 60.77%, amounting to ¥275,331,117.53 compared to ¥701,776,323.32 in the previous year[5] - Cash inflows from operating activities totaled ¥8,440,014,881.01, a rise of 8.2% from ¥7,801,946,286.47 in the previous year[22] - The company reported a total cash outflow from operating activities of ¥8,164,683,763.48, which is an increase of 15.0% compared to ¥7,100,169,963.15 in the previous year[22] - The net cash flow from financing activities was -¥226,598,554.56, worsening from -¥104,917,741.81 in the previous year[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥16,082,498,905.81, down 6.06% from ¥17,120,851,592.43 at the end of the previous year[5] - Total liabilities decreased to ¥9,883,013,767.06 from ¥11,029,338,906.75, a reduction of 10.41%[17] - Cash and cash equivalents at the end of the period were ¥2,853,572,169.25, down from ¥2,885,462,449.66, a decrease of 1.10%[16] - Accounts receivable decreased to ¥7,942,072,887.18 from ¥8,421,185,110.43, a decline of 5.67%[16] - Inventory increased to ¥2,617,349,058.70 from ¥2,561,699,128.54, an increase of 2.17%[16] - The company reported a decrease in short-term borrowings to ¥3,084,063,485.60 from ¥3,787,853,711.27, a reduction of 18.54%[17] - The total equity increased to ¥6,199,485,138.75 from ¥6,091,512,685.68, reflecting a growth of 1.78%[17] Other Income and Expenses - Other income decreased by 35.72% to ¥6,436,318.52 compared to ¥10,013,086.82 in the previous period[9] - Investment income showed a significant change, with a profit of ¥239,798.53 compared to a loss of ¥236,767.93 in the previous year, marking a 201.28% increase[9] - The company reported a substantial increase in operating income, with other operating income rising by 3437.83% to ¥11,569,023.03 from ¥327,009.35[9] - Total operating costs for Q1 2024 were ¥7,289,981,773.84, up from ¥6,614,124,799.91, reflecting a year-over-year increase of 10.18%[19] Investment Activities - Cash flow from investment activities increased by 760.30% to ¥12,509,583.87 due to the disposal of subsidiaries[9] - In Q1 2024, the total cash outflow from investment activities decreased by 59.91% to ¥3,691,581.05, primarily due to reduced capital expenditures[10] - Cash inflow from investment activities increased significantly by 313.72% to ¥8,818,002.82, attributed to higher cash inflows from investment activities[10] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 24,943, with no preferred shareholders[12] - The largest shareholder, China Everbright Medical Health Industry Co., Ltd., holds 14.36% of the shares, totaling 41,876,431 shares[12] - The second-largest shareholder, China Everbright Group Co., Ltd., holds 14.12% of the shares, totaling 41,180,805 shares[12] - The company reported a 67.59% decrease in cash received from minority shareholders' investments, totaling ¥9,450,000.00[10] - The company experienced a 149.63% increase in cash received from other financing activities, totaling ¥22,965,642.98, due to increased borrowings from minority shareholders[10]